Picture of Bal Pharma logo

BALPHARMA — Bal Pharma News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Bal Pharma Gets Shareholders' Nod For Increase In The Investment Limits Of NRIs And FPIs

Sept 24 (Reuters) - Bal Pharma Ltd  BALP.NS :
    * GETS SHAREHOLDERS' NOD FOR INCREASE IN THE INVESTMENT
LIMITS OF
NRIS AND FPIS

Source text for Eikon:  ID:nBSE6XRnvz 
Further company coverage:  BALP.NS 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Bal Pharma

See all news